Tantum Verde Global
A site of Angelini Pharma
A heritage you can trust
Celebrating 50 years of healthy throats and mouths, worldwide.
Some of the world’s greatest stories start with a scientific discovery. This one starts in 1967, with the researchers at Angelini synthesizing an anti-inflammatory molecule. It would soon be known as benzydamine, and then in the 1970s, as Tantum Verde. Now it’s known as an established range of sore throat and mouth disorder products. And recognised internationally for its clinically tested benefits.
We could measure the success of Tantum Verde in numbers. The fact that it’s available in almost 70 countries worldwide. And backed up by a robust clinical evidence base. Or we could measure it in the things that really matter to us: laughter and smiles and songs and conversations – all the things we need a healthy throat and mouth for, to truly make the most of the time with the people we love.
Spending quality time with the ones nearest and dearest to us. It’s what we have prided ourselves in protecting, for over 50 years.
Spending quality time with the ones nearest and dearest to us. It’s what we have prided ourselves in protecting, for over 50 years.
-
1967
The success story begins. Angelini creates benzydamine.
-
1972
Growing global: Tantum Verde launches as an oral solution in Italy before quickly expanding to other countries.
-
1982
The innovation continues: introducing the spray format.
-
1990
Sore throat relief made even easier with the launch of lozenges.
-
2020
Celebrating 50 years as a leading choice for consumers and physicians.
About us
Angelini Pharma is a world-class pharmaceutical company and a member of the Angelini Group. We had our humble beginnings as a small pharmaceutical laboratory in Italy, in 1919. Fast forward to a century later, and Angelini Pharma has grown into a leading international player, present in 25 countries with a staff of more than 3,000 people. And marketing products in more than 70 countries worldwide.
At Angelini Pharma, we work every day to make a difference to patients’ lives. We are focused specifically on the areas of Mental Health (including Pain), Central Nervous System, Rare Diseases and Consumer Healthcare. What drives us is the desire to offer people, patients and their loved ones new medicines that improve both health and quality of life.
In Consumer Healthcare, Angelini Pharma is known for the discovery and development of benzydamine. Angelini Pharma has also played a pioneering role in the development of antidepressants and mood stabilisers. In addition, we are continuously committed to finding new treatment options for rare diseases and epilepsy.
Lea las instrucciones
Consulte al farmacéutico